Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Vasoregulating Compounds and Methods of Their Use

  • Read more about Vasoregulating Compounds and Methods of Their Use
European Patent
03774543.7
Filed on 2003-10-03

VASOREGULATING COMPOUNDS AND METHODS OF THEIR USE

  • Read more about VASOREGULATING COMPOUNDS AND METHODS OF THEIR USE
US Patent 7,364,719
Filed on 2005-03-24

TREATMENT OF KAPOSI'S SARCOMA WITH IL-12

  • Read more about TREATMENT OF KAPOSI'S SARCOMA WITH IL-12
Japan
2002-569833
Filed on 2000-05-15

Preparation Of Polyethylene Glycol (PEG)-Containing Carbohydrate-Encapsulated Hybrid Quantum Dots For Biological Imagingas

  • Read more about Preparation Of Polyethylene Glycol (PEG)-Containing Carbohydrate-Encapsulated Hybrid Quantum Dots For Biological Imagingas
Patent Cooperation Treaty
PCT/US2005/09344
Filed on 2005-03-22

Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid

  • Read more about Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid
European Patent
03773233.6
Filed on 2003-10-08

Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid

  • Read more about Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid
US Patent 7,572,828
Filed on 2005-03-22

Formylpeptide Receptor (FPR) as a Target for Anti-Malignant Glioma Therapy

  • Read more about Formylpeptide Receptor (FPR) as a Target for Anti-Malignant Glioma Therapy
Patent Cooperation Treaty
PCT/US2005/05652
Filed on 2005-02-22

Nucleic Acid and Amino Acid Sequences of Hemoglobin-Response Genes in Candida Albicans and the Use of RReagents Derived From These Sequences in the Diagnosis of Disseminated Candida Albicans Infection

  • Read more about Nucleic Acid and Amino Acid Sequences of Hemoglobin-Response Genes in Candida Albicans and the Use of RReagents Derived From These Sequences in the Diagnosis of Disseminated Candida Albicans Infection
US Patent 7,332,167
Filed on 2005-02-18

Wip1 Phosphatase Chemical Inhibitors Screening

  • Read more about Wip1 Phosphatase Chemical Inhibitors Screening
Patent Cooperation Treaty
PCT/US2005/08116
Filed on 2005-03-11

Cytonectin Gene And Related Antibodies In Tauopathy, Cancer And Arthritis

  • Read more about Cytonectin Gene And Related Antibodies In Tauopathy, Cancer And Arthritis
Patent Cooperation Treaty
PCT/US2005/05793
Filed on 2005-02-23

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1046
  • Page 1047
  • Page 1048
  • Page 1049
  • Page 1050
  • Page 1051
  • Page 1052
  • Page 1053
  • Page 1054
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health